Gene Therapy Market is projected to reach USD 38.33 Billion by 2030, growing at a CAGR of 22.2% during the forecast period of 2023-2030 - published by MarketDigits

Gene Therapy Market Scope:
Market size value in 2023 - USD 9.42 Billion
Market size value in 2030 - USD 38.33 Billion
CAGR (2023-2030) - 22.2%
Forecast Period - 2023-2030
Segments Covered - Technology, Therapy Type, Therapeutic Area, End User & Region.
Geographies Covered - North America, Europe, Asia Pacific, and Row
Sample of Companies Covered - Sibiono GeneTech Co., Ltd, Shanghai Sunway Biotech Co., Ltd., Gensight Biologics S.A., Transgene, Calimmune, Inc., Epeius Biotechnologies Corp., Astellas Pharma Inc., American Gene Technologies, BioMarin Pharmaceuticals Inc.

Download Sample Pages-https://www.marketdigits.com/request/sample/277

Browse in-depth TOC on "Gene Therapy Market"
178-Tables
95-Figures
332-Pages

North America dominates the market for Gene Therapy.
North America emerged as the leading market, commanding a substantial 67.56% share of the total revenue. Projections indicate that this region is poised to solidify its position as the primary hub for routine gene therapy manufacturing, both in terms of approval numbers and revenue generation throughout the forecast period. The market is anticipated to benefit from heightened research and development investments by both major industry players and smaller enterprises dedicated to crafting optimal therapeutic drugs. These developments are expected to contribute significantly to the continued growth and advancement of the Gene Therapy Market.
The market is experiencing momentum due to rising government investments and the escalating incidence of targeted diseases. As per data from the Spinal Muscular Atrophy Foundation, in 2020, spinal muscular atrophy impacted a notable population of 10,000 to 25,000 children and adults in the United States. This prevalence underscores the significance of addressing rare diseases, and it contributes to the market's growth trajectory.

Ask for Discount- https://www.marketdigits.com/request/discount/277

Top Key Players Covered in the Report-
Regenxbio, Inc., xford BioMedica plc, Dimension Therapeutics, Inc., Bristol-Myers Squibb Company, SANOFI, Applied Genetic Technologies Corporation, F. Hoffmann-La Roche Ltd, Bluebird Bio, Inc., Novartis AG, Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics), UniQure N.V., Shire Plc, Cellectis S.A., Sangamo Therapeutics, Inc, Orchard Therapeutics, Gilead Lifesciences, Inc., BENITEC BIOPHARMA, Sibiono GeneTech Co., Ltd, Shanghai Sunway Biotech Co., Ltd., Gensight Biologics S.A., Transgene, Calimmune, Inc., Epeius Biotechnologies Corp., Astellas Pharma Inc., American Gene Technologies, BioMarin Pharmaceuticals Inc. and Others.

For More Information - Inquire Now!
https://www.marketdigits.com/request/enquiry-before-buying/277

Recent Developments-
In January 2024, Biogen and Ginkgo Bioworks announced the completion of their gene therapy collaboration involving AAV based vectors. This is expected to fuel the demand for gene therapies in the coming years.

https://industrytoday.co.uk/market-research-industry-today/emerging-trends-and-innovations-for-the-gene-therapy-market-projected-to-reach-usd-3833-billion-by-2030

MarketDigits
Email: sales@marketdigits.com

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

This release was published on openPR.